A Novel 8-Color Flow Cytometry Panel to Study Activation,Maturation and Senescence of CD4 and CD8 T Lymphocytes in HIV-Infected Individuals at Different Stages of Disease

Abstract

Multicolor flow cytometry allows to study the markers differentially expressed during maturation, activation, function and senescence on immune cells. Despite the availability of reagents and technology, scarce agreement has been gained regarding phenotypic markers of HIV disease progression other than CD4 T-cell count. In this work, we present a novel high-throughput global analysis of CD4 and CD8 T-lymphocyte profiles by standardized 8-color combinations of antibodies aimed at analyzing HIV disease course progression. For this purpose, two tubes with lyophilized reagent cocktails (CD4-and CD8-specific tubes) were designed to compare the immunological characteristics of HIV-infected persons (37 “high CD4” HAART-treated and 32 “low CD4” naïve or failed-treatment patients) with healthy donors (HD). In particular, T-cell activation (CD25, CD38, CD69), differentiation (CD45RA, CCR7), apoptosis (CD95) and immune suppression profiles (CD25^highCD127-) in HIV+ patients were compared with HD. Statistical analysis was performed by identifying the parameters associated with disease progression, namely markers that were found to be significantly different between groups with high CD4 counts (including HD) and low CD4 counts (restricted to HIV patients) but not between the HD and the “high CD4” group. This set of markers, including those identifying different maturation and senescence subtypes of CD4 and CD8 T cells, was found to be associated with therapy failure, and it is in fact evaluated in an ongoing study aimed to verify its prognostic value. This robust assay was found feasible on a semi-routine scale for HIV-infected persons, and allows for broader clinical studies aimed at defining markers associated with treatment outcome, possibly having a high impact on the clinical management of HIV disease.

Keywords

high-throughput whole blood 8-color flow cytometry CD4 and CD8 T-lymphocytes HIV disease

References

Newman

Nicodemus

Ordonez

Stone

. Lymphocyte phenotyping by fluorescence microscopy and flow cytometry: Results in homosexual men and heterosexual controls. AIDS Res 1983; 1:127–34.

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (January 10, 2011). (http://wwwaidsinfonihgov/ContentFiles/AdultandAdolescentGLpdf) 2011.

Palella

Jr Delaney

Moorman

Loveless

Fuhrer

Satten

Aschman

Holmberg

. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853–60.

Paci

Martini

Bernaschi

D'Offizi

Castiglione

. Timely HAART initiation may pave the way for a better viral control. BMC Infect Dis 2011; 11:56.

Piroth

Fournel

Mahy

. A decision tree to help determine the best timing and antiretroviral strategy in HIV-infected patients. Epidemiol Infect 2011; 1–10.

Schmid

Gianella

von Wyl

. Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection. PLoS One 2010; 5:e13310.

Chun

Justement

Murray

. Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: Implications for eradication. AIDS 2010; 24:2803–8.

Bautista-Arredondo

Martz

Wirtz

Bertozzi

. Optimizing HIV treatment programs. Curr Opin HIV AIDS 2010; 5:232–6.

Zoufaly

an der

Kollan

. Clinical outcome of HIV-infected patients with discordant virological and immunological response to antiretroviral therapy. J Infect Dis 2011; 203:364–71.

10.

Giorgi

Liu

Hultin

Cumberland

Hennessey

Detels

. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: Results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1993; 6:904–12.

11.

Giorgi

Hultin

McKeating

. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179:859–70.

12.

Testi

D'Ambrosio

Santoni

. The CD69 receptor: A multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 1994; 15:479–83.

13.

Chattopadhyay

Roederer

. Good cell, bad cell: Flow cytometry reveals T-cell subsets important in HIV disease. Cytometry A 2010; 77:614–22.

14.

Appay

Sauce

. Immune activation and inflammation in HIV-1 infection: Causes and consequences. J Pathol 2008; 214:231–41.

15.

Lanzavecchia

Sallusto

. Dynamics of T lymphocyte responses: Intermediates, effectors, and memory cells. Science 2000; 290:92–7.

16.

Poonia

Pauza

Salvato

. Role of the Fas/FasL pathway in HIV or SIV disease. Retrovirology 2009; 6:91.

17.

Seddiki

Santner-Nanan

Martinson

. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203:1693–700.

18.

Ladell

Hellerstein

Cesar

Busch

Boban

McCune

. Central memory CD8+ T cells appear to have a shorter lifespan and reduced abundance as a function of HIV disease progression. J Immunol 2008; 180:7907–18.

19.

Ganesan

Chattopadhyay

Brodie

Qin

Mascola

Michael

Follmann

Roederer

. Immunologic and virologic events in early HIV infection predict subsequent rate of progression. J Infect Dis 2010; 201:272–84.

20.

BD Lyoplates Technology. (http://wwwbdbeuropecom/images/bdb/dm/07000GEN008001_XEUR0168pdf) 2011.

21.

BD Cytometer Setup and Tracking Beads. (http://wwwbdbiosciencescom/documents/BD_Cytometer_Setup_Trackingpdf) 2011.

22.

Piconi

Trabattoni

Gori

. Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy. AIDS 2010; 24:1991–2000.

23.

Dianzani

Funaro

DiFranco

. Interaction between endothelium and CD4+CD45RA+ lymphocytes. Role of the human CD38 molecule. J Immunol 1994; 153:952–9.

24.

Dyrhol-Riise

Voltersvik

Olofsson

Asjo

. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection. AIDS 1999; 13:2365–76.

25.

Liu

Cumberland

Hultin

Prince

Detels

Giorgi

. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retroviral 1997; 16:83–92.

26.

Onlamoon

Tabprasit

Suwanagool

Louisirirotchanakul

Ansari

Pattanapanyasat

. Studies on the potential use of CD38 expression as a marker for the efficacy of anti-retroviral therapy in HIV-1-infected patients in Thailand. Virology 2005;341:238–47.

27.

Liu

Hultin

Cumberland

Hultin

Schmid

Matud

Detels

Giorgi

. Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: Results of 6 years of follow-up. Cytometry 1996;26:1–7.

28.

Bai

Bellistri

Tincati

. Reduced CD127 expression on peripheral CD4+ T cells impairs immunological recovery in course of suppressive highly active antiretroviral therapy. AIDS 2010; 24:2590–3.

29.

Zauli

Gibellini

Secchiero

Dutartre

Olive

Capitani

Collette

. Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway. Blood 1999; 93:1000–10.

30.

Andersson

Boasso

Nilsson

Zhang

Shire

Lindback

Shearer

Chougnet

. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 2005; 174:3143–7.

31.

Suzuki

Gatanaga

Oka

. High frequency and proliferation of CD4+ FOXP3+ Treg in HIV-1-infected patients with low CD4 counts. Eur J Immunol 2009; 39:301–9.

32.

Card

McLaren

Wachihi

Kimani

Plummer

Fowke

. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+) CD25(+)FOXP3(+) regulatory T cells. J Infect Dis 2009;199:1318–22.